Literature DB >> 16832044

Profile of Rino Rappuoli.

Bijal Trivedi.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16832044      PMCID： PMC1544134          DOI： 10.1073/pnas.0604892103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

1.  Mutants of pertussis toxin suitable for vaccine development.

Authors:  M Pizza; A Covacci; A Bartoloni; M Perugini; L Nencioni; M T De Magistris; L Villa; D Nucci; R Manetti; M Bugnoli
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

2.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

3.  An immunological study of the diphtheria toxin molecule.

Authors:  A M Pappenheimer; T Uchida; A A Harper
Journal:  Immunochemistry       Date:  1972-09

4.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.

Authors:  S Censini; C Lange; Z Xiang; J E Crabtree; P Ghiara; M Borodovsky; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 5.  Cellular microbiology emerging.

Authors:  P Cossart; P Boquet; S Normark; R Rappuoli
Journal:  Science       Date:  1996-01-19       Impact factor: 47.728

6.  Mutation in the structural gene for diphtheria toxin carried by temperate phage .

Authors:  T Uchida; D M Gill; A M Pappenheimer
Journal:  Nat New Biol       Date:  1971-09-01

7.  MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice.

Authors:  D A Higgins; J R Carlson; G Van Nest
Journal:  Vaccine       Date:  1996-04       Impact factor: 3.641

8.  Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.

Authors:  H Tettelin; N J Saunders; J Heidelberg; A C Jeffries; K E Nelson; J A Eisen; K A Ketchum; D W Hood; J F Peden; R J Dodson; W C Nelson; M L Gwinn; R DeBoy; J D Peterson; E K Hickey; D H Haft; S L Salzberg; O White; R D Fleischmann; B A Dougherty; T Mason; A Ciecko; D S Parksey; E Blair; H Cittone; E B Clark; M D Cotton; T R Utterback; H Khouri; H Qin; J Vamathevan; J Gill; V Scarlato; V Masignani; M Pizza; G Grandi; L Sun; H O Smith; C M Fraser; E R Moxon; R Rappuoli; J C Venter
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

9.  Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

Authors:  K G Nicholson; A E Colegate; A Podda; I Stephenson; J Wood; E Ypma; M C Zambon
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

10.  Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.

Authors:  Manuel R Amieva; Roger Vogelmann; Antonello Covacci; Lucy S Tompkins; W James Nelson; Stanley Falkow
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.